European
Platform for Patients Organisations, Science and Industry appoints new head
Brussels, 20 December 2005: EuropaBio
welcomes the appointment of Michael Griffith, as the new Chairman of the
European Platform for Patient’s Organisations, Science and Industry (EPPOSI)
of which EuropaBio is a supporting member. He takes over from Ysbrand Poortman
who steps down as Chair after 3 years but will continue serving on the EPPOSI
board.
EPPOSI is a patient led partner organisation, which has been operating on a
European level out of Brussels for the past 10 years. It aims to establish
consensus on healthcare issues relating to the development of therapies,
diagnostics and devices and to meet unmet medical needs. It holds an annual
workshop on therapy development in different European capitals, at which
experts from the different sectors speak on the challenges to developing
therapies for the thousands of conditions, which are still untreatable. In the
past these workshops have focused largely on rare diseases.
EPPOSI also holds workshops on such important issues as the value of
innovation, which in the current economic climate in Europe is of great
importance, not only to patients but also to industry and governments.
Mr Griffith is Chief Executive of the Irish charity Fighting Blindness and
Chair of the Medical Research Charities Group in Ireland and Debra Ireland. A
former banker Michael has been working in a voluntary and professional
capacity with research charities for over 20 years, and was largely
responsible for the establishment and development of the two charities
Fighting Blindness and Debra Ireland. He has been working with EPPOSI as a
member of the Executive Committee for the last 5 years and has recently
initiated a project to establish an Irish version of the European Platform,
designed to bring the work of the European Platform back to Ireland.
In addition to working with the Irish charities, Mr Griffith also works
internationally both with the fighting blindness societies (Retina
International) and the EB societies (Debra International) and is member of the
Board of the European Genetic Alliances’ Network (EGAN)
For more information, contact
Avril Daly, Fighting Blindness Tel +353 1 709 30 50 /
Avril.daly@fightingblindness.ie
Adeline Farrelly, EuropaBio Tel: +32 2 735 0313 Direct: +32 2 739 1174
Mobile: +32 475 93 17 24 Email:
a.farrelly@europabio.org
EPPOSI - www.epposi.org
Fighting Blindness -
www.fightingblindness.ie
Debra International -
www.debraireland.org
The Medical Research Charities Group (MRCG) -
www.mrcg.ie
EGAN – European Genetic Alliances’ Network
About EuropaBio
EuropaBio, the European Association for Bioindustries, has 50 direct members
operating worldwide and 25 national biotechnology associations representing
some 1500 small and medium sized enterprises involved in research and
development, testing, manufacturing and distribution of biotechnology
products.
http://www.europabio.org